Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eva Wardelmann

Showing results (231-240 of 248) with videos related to

Pageof 25
Sort By:
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
JAMA Surgery|April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant ImatinibAlessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2015
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing SarcomaKonstantin Agelopoulos, Günther H S Richter, Eva Schmidt, et al.
Journal of Cancer Policy|December 13, 2024
Breaking barriers: The impact of telemedicine on improving soft tissue and bone tumor management in ArmeniaRuzanna Papyan, Shushan Hovsepyan, Julieta Hoveyan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
Transplantation|July 12, 2018
Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular CarcinomaNils Heits, Mario Brosch, Alexander Herrmann, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Pageof 25

Showing results (231-240 of 248) with videos related to

Sort By:
Pageof 25
Oncology Research and Treatment|April 22, 2021
Utilization of Interdisciplinary Tumor Boards for Sarcoma Care in Germany: Results from the PROSa StudyMartin Eichler, Dimosthenis Andreou, Henriette Golcher, et al.
JAMA Surgery|April 3, 2020
Quality of Surgery and Outcome in Localized Gastrointestinal Stromal Tumors Treated Within an International Intergroup Randomized Clinical Trial of Adjuvant ImatinibAlessandro Gronchi, Sylvie Bonvalot, Andres Poveda Velasco, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 17, 2015
Deep Sequencing in Conjunction with Expression and Functional Analyses Reveals Activation of FGFR1 in Ewing SarcomaKonstantin Agelopoulos, Günther H S Richter, Eva Schmidt, et al.
Journal of Cancer Policy|December 13, 2024
Breaking barriers: The impact of telemedicine on improving soft tissue and bone tumor management in ArmeniaRuzanna Papyan, Shushan Hovsepyan, Julieta Hoveyan, et al.
European Journal of Cancer (Oxford, England : 1990)|January 4, 2023
Controversies in the management of patients with soft tissue sarcoma: Recommendations of the Conference on State of Science in Sarcoma 2022Christian Rothermundt, Dimosthenis Andreou, Jean-Yves Blay, et al.
Genes, Chromosomes & Cancer|June 6, 2020
Germline SDHB-inactivating mutation in gastric spindle cell sarcomaChristoph E Heilig, Peter Horak, Daniel B Lipka, et al.
JAMA Oncology|October 16, 2025
Guidelines for Next-Generation Sequencing in Sarcoma Diagnosis and Treatment: A Consensus ReviewCésar Serrano, Sebastian Bauer, Jean-Yves Blay, et al.
Transplantation|July 12, 2018
Evolutionary Distance Predicts Recurrence After Liver Transplantation in Multifocal Hepatocellular CarcinomaNils Heits, Mario Brosch, Alexander Herrmann, et al.
Nature Medicine|June 7, 2017
Corrigendum: SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Nature Medicine|December 20, 2016
SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemiaConstanze Schneider, Thomas Oellerich, Hanna-Mari Baldauf, et al.
Pageof 25